Cargando…
Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
BACKGROUND: Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary st...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231013/ https://www.ncbi.nlm.nih.gov/pubmed/34168025 http://dx.doi.org/10.1136/bmjopen-2020-045568 |
_version_ | 1783713336452448256 |
---|---|
author | Cruickshank, Moira Newlands, Rumana Blazeby, Jane Ahmed, Irfan Bekheit, Mohamed Brazzelli, Miriam Croal, Bernard Innes, Karen Ramsay, Craig Gillies, Katie |
author_facet | Cruickshank, Moira Newlands, Rumana Blazeby, Jane Ahmed, Irfan Bekheit, Mohamed Brazzelli, Miriam Croal, Bernard Innes, Karen Ramsay, Craig Gillies, Katie |
author_sort | Cruickshank, Moira |
collection | PubMed |
description | BACKGROUND: Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary studies and ultimately negatively impacts on decision making by all stakeholders. Core outcome sets offer a potential solution to this problem of heterogeneity and concerns over whether the ‘right’ outcomes are being measured. One of the first steps in core outcome set generation is to identify the range of outcomes reported (in the literature or by patients directly) that are considered important. OBJECTIVES: To develop a systematic map that examines the variation in outcome reporting of interventions for uncomplicated symptomatic gallstone disease, and to identify other outcomes of importance to patients with gallstones not previously measured or reported in interventional studies. RESULTS: The literature search identified 794 potentially relevant titles and abstracts of which 137 were deemed eligible for inclusion. A total of 129 randomised controlled trials, 4 gallstone disease specific patient-reported outcome measures (PROMs) and 8 qualitative studies were included. This was supplemented with data from 6 individual interviews, 1 focus group (n=5 participants) and analysis of 20 consultations. A total of 386 individual recorded outcomes were identified across the combined evidence: 330 outcomes (which were reported 1147 times) from trials evaluating interventions, 22 outcomes from PROMs, 17 outcomes from existing qualitative studies and 17 outcomes from primary qualitative research. Areas of overlap between the evidence sources existed but also the primary research contributed new, unreported in this context, outcomes. CONCLUSIONS: This study took a rigorous approach to catalogue and map the outcomes of importance in gallstone disease to enhance the development of the COS ‘long’ list. A COS for uncomplicated gallstone disease that considers the views of all relevant stakeholders is needed. |
format | Online Article Text |
id | pubmed-8231013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82310132021-07-09 Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set Cruickshank, Moira Newlands, Rumana Blazeby, Jane Ahmed, Irfan Bekheit, Mohamed Brazzelli, Miriam Croal, Bernard Innes, Karen Ramsay, Craig Gillies, Katie BMJ Open Surgery BACKGROUND: Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary studies and ultimately negatively impacts on decision making by all stakeholders. Core outcome sets offer a potential solution to this problem of heterogeneity and concerns over whether the ‘right’ outcomes are being measured. One of the first steps in core outcome set generation is to identify the range of outcomes reported (in the literature or by patients directly) that are considered important. OBJECTIVES: To develop a systematic map that examines the variation in outcome reporting of interventions for uncomplicated symptomatic gallstone disease, and to identify other outcomes of importance to patients with gallstones not previously measured or reported in interventional studies. RESULTS: The literature search identified 794 potentially relevant titles and abstracts of which 137 were deemed eligible for inclusion. A total of 129 randomised controlled trials, 4 gallstone disease specific patient-reported outcome measures (PROMs) and 8 qualitative studies were included. This was supplemented with data from 6 individual interviews, 1 focus group (n=5 participants) and analysis of 20 consultations. A total of 386 individual recorded outcomes were identified across the combined evidence: 330 outcomes (which were reported 1147 times) from trials evaluating interventions, 22 outcomes from PROMs, 17 outcomes from existing qualitative studies and 17 outcomes from primary qualitative research. Areas of overlap between the evidence sources existed but also the primary research contributed new, unreported in this context, outcomes. CONCLUSIONS: This study took a rigorous approach to catalogue and map the outcomes of importance in gallstone disease to enhance the development of the COS ‘long’ list. A COS for uncomplicated gallstone disease that considers the views of all relevant stakeholders is needed. BMJ Publishing Group 2021-06-24 /pmc/articles/PMC8231013/ /pubmed/34168025 http://dx.doi.org/10.1136/bmjopen-2020-045568 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Surgery Cruickshank, Moira Newlands, Rumana Blazeby, Jane Ahmed, Irfan Bekheit, Mohamed Brazzelli, Miriam Croal, Bernard Innes, Karen Ramsay, Craig Gillies, Katie Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
title | Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
title_full | Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
title_fullStr | Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
title_full_unstemmed | Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
title_short | Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
title_sort | identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231013/ https://www.ncbi.nlm.nih.gov/pubmed/34168025 http://dx.doi.org/10.1136/bmjopen-2020-045568 |
work_keys_str_mv | AT cruickshankmoira identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT newlandsrumana identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT blazebyjane identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT ahmedirfan identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT bekheitmohamed identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT brazzellimiriam identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT croalbernard identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT inneskaren identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT ramsaycraig identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset AT gillieskatie identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset |